EDBI Logo
|  

Category: Portfolio News

Portfolio News

ArteraAI Secures $20 Million in Funding to Further Personalize Cancer Therapy With Multimodal AI

ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announced today that it has secured an additional $20 million
  • 01 02 2024
  • |
Read More

Portfolio News

AI market intelligence platform AlphaSense snags strategic investment from EDBI

THE investing arm of the Economic Development Board of Singapore, EDBI, has made an undisclosed strategic investment into artificial intelligence (AI) market intelligence platform
  • 18 01 2024
  • |
Read More

Portfolio News

Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)

Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
  • 19 10 2023
  • |
Read More

Portfolio News

EDBI-Backed Singapore Fintech Startup Thunes Wants To Take On SWIFT

EDBI-Backed Singapore Fintech Startup Thunes Wants To Take On SWIFT
  • 04 08 2023
  • |
Read More

Portfolio News

Singapore-headquartered Mirxes secures US$50 mil in Series D funding; files listing application with HKEx

Singapore-headquartered Mirxes secures US$50 mil in Series D funding; files listing application with HKEx
  • 26 07 2023
  • |
Read More

Portfolio News

Ambiq Achieves Milestone of Powering Over 200 Million IoT Devices

Austin, TX and Singapore, 13 June 2023 – Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency,
  • 13 07 2023
  • |
Read More

Portfolio News

EdgeQ Closes $75M Series-B Investment and Ramps to Customers’ Demand for Its Award-Winning 5G+AI Base Station-on-a-Chip for 5G Networks

Lattice Semiconductor CEO Jim Anderson Joins the Board of Directors as the Company Enters into Customer Deployments of Private 5G and Open RAN Networks
  • 02 05 2023
  • |
Read More

Portfolio News

Proxtera announces successful first close, of Series Seed round of funding with Ant Group, CerraCap Ventures, and EDBI

The funding will be used as working capital to further develop the company’s innovative digital cross-border trade and financial services enabled by trusted credentials.
  • 30 03 2023
  • |
Read More

Portfolio News

Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion

The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well
  • 24 10 2022
  • |
Read More

Portfolio News

ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors

ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors. Anzu Partners led the $14M financing round with participation from Amgen
  • 20 09 2022
  • |
Read More

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now

Investing in high-growth technologies that shape the future economic pillars of Singapore since 1991.

About EDBI

Team

Portfolio

News and Insights

Careers

Contact Us

Linkedin Youtube

© 2023 EDBI. All rights reserved.